Corient Private Wealth LLC Has $4.86 Million Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Corient Private Wealth LLC raised its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 16.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,182 shares of the biotechnology company's stock after acquiring an additional 1,146 shares during the quarter. Corient Private Wealth LLC's holdings in Axon Enterprise were worth $4,863,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in AXON. Asset Dedication LLC increased its stake in Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock valued at $106,000 after buying an additional 18 shares during the period. Bleakley Financial Group LLC increased its stake in shares of Axon Enterprise by 1.3% in the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock worth $908,000 after acquiring an additional 20 shares during the last quarter. Venturi Wealth Management LLC raised its holdings in shares of Axon Enterprise by 2.7% during the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock worth $477,000 after acquiring an additional 21 shares in the last quarter. Insigneo Advisory Services LLC boosted its position in Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock valued at $627,000 after purchasing an additional 22 shares during the last quarter. Finally, Menard Financial Group LLC boosted its position in Axon Enterprise by 0.8% during the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock valued at $1,204,000 after purchasing an additional 24 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company's stock.

Remove Ads

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the firm's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the sale, the director now directly owns 1,627 shares in the company, valued at $899,275.44. This trade represents a 15.87 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business's stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

AXON has been the subject of a number of recent research reports. Craig Hallum downgraded Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. Morgan Stanley upgraded shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and lifted their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. TD Cowen began coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a "buy" rating and a $700.00 price target on the stock. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Finally, Northcoast Research lowered Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $604.67.

Axon Enterprise Stock Performance

NASDAQ AXON traded up $4.66 during trading on Tuesday, hitting $577.18. The company's stock had a trading volume of 439,520 shares, compared to its average volume of 835,219. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The firm has a market cap of $44.23 billion, a P/E ratio of 149.14, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The firm has a 50 day moving average price of $591.92 and a 200 day moving average price of $546.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.